Waters logo

WatersNYSE: WAT

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 November 1995

Next earnings report:

07 November 2024

Last dividends:

26 November 1996

Next dividends:

N/A
$22.95 B
0%vs. 3y high
96%vs. sector
-vs. 3y high
-vs. sector
-77.71
-201%vs. 3y high
1%vs. sector
-4%vs. 3y high
71%vs. sector

Price

regular market | 7 min ago
$386.65+$0.65(+0.17%)

Dividend

No data over the past 3 years
$740.30 M$853.27 M
$740.30 M$161.50 M

Analysts recommendations

Institutional Ownership

WAT Latest News

Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
zacks.com04 November 2024 Sentiment: -

WAT's third-quarter 2024 results show growth in the pharma and industrial sectors. A dip in China sales creates headwinds.

Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates
investopedia.com01 November 2024 Sentiment: POSITIVE

Waters Corp. (WAT) saw its shares jump by almost 20% on Friday, making it the best performer in the S&P 500 for the day. This increase followed the company's announcement of third-quarter sales and earnings that exceeded what analysts had expected.

S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
investopedia.com01 November 2024 Sentiment: POSITIVE

After two days of poor trading, major U.S. stock indexes ended the week positively, rising on Friday. Investors were encouraged by strong earnings reports from Amazon, a giant in e-commerce and cloud computing.

Waters Corp raises annual profit forecast on higher demand for lab equipment
reuters.com01 November 2024 Sentiment: POSITIVE

Waters Corp increased its yearly profit prediction after surpassing Wall Street's expectations for third-quarter earnings and revenue on Friday. This improvement was due to higher demand for its products and services used in drug development and research.

Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results
prnewswire.com01 November 2024 Sentiment: POSITIVE

Waters Corporation reported sales of $740 million for the third quarter of 2024, surpassing expectations with a 4% increase in both reported and constant currency. All regions and end markets, particularly Pharma & Industrial, showed growth, while recurring revenue rose by high single digits in constant currency. The company also raised its full-year sales and earnings per share guidance, anticipating 5% to 7% growth in constant currency for the fourth quarter.

Waters Corporation (WAT) Q3 2024 Earnings Call Transcript
seekingalpha.com01 November 2024 Sentiment: POSITIVE

Waters Corporation (NYSE:WAT) will hold its Q3 2024 Earnings Conference Call on November 1, 2024, at 8:00 AM ET. The call will feature company representatives, including Caspar Tudor, Udit Batra, and Amol Chaubal, along with analysts from various financial firms. Participants will be in listen-only mode until the Q&A session starts.

Sailing In International Waters With LVHI
seekingalpha.com29 October 2024 Sentiment: POSITIVE

I steer clear of investing in non-democratic countries because of "Regime Risk," which can make usual stock-picking strategies useless very quickly. The MSCI World Index consistently does worse than the S&P 500, indicating that investing in international stocks might not be a good idea. The Franklin International Low Volatility High Dividend Index ETF provides better risk management and dividend opportunities, making it a valuable part of my investment portfolio.

Waters (WAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
zacks.com25 October 2024 Sentiment: POSITIVE

Waters (WAT) has the right mix of two important factors that could lead to a strong earnings report soon. Be ready for the main expectations.

Why Waters (WAT) is Poised to Beat Earnings Estimates Again
zacks.com23 October 2024 Sentiment: POSITIVE

Waters (WAT) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
prnewswire.com10 October 2024 Sentiment: POSITIVE

Waters has introduced new LC-MS grade reagents, enzymes, and software that make it easier to analyze large RNA molecules. This advancement helps speed up the development of mRNA vaccines, personalized cancer treatments, and new drugs for genetic diseases. The new digestion enzymes provide full RNA sequence coverage for better analysis, while the LC-MS-grade reagents enhance sensitivity and accuracy in detecting RNA components.

What type of business is Waters?

Waters Corporation is an American company specializing in the development and provision of measuring instruments and tools. It was founded in 1958, with its headquarters located in Milford, Massachusetts. The company's activities include the development, production, sales, and servicing of high-performance liquid chromatography (HPLC) systems, ultra high-performance liquid chromatography (UHPLC) systems, and mass spectrometry technological systems and products, including chromatographic columns, other consumables, and comprehensive post-warranty service plans. Additionally, the company develops and manufactures instruments for thermal analysis, rheometry, and calorimetry, as well as modern software solutions that interact with the equipment and systems.

What sector is Waters in?

Waters is in the Healthcare sector

What industry is Waters in?

Waters is in the Diagnostics & Research industry

What country is Waters from?

Waters is headquartered in United States

When did Waters go public?

Waters initial public offering (IPO) was on 17 November 1995

What is Waters website?

https://www.waters.com

Is Waters in the S&P 500?

Yes, Waters is included in the S&P 500 index

Is Waters in the NASDAQ 100?

No, Waters is not included in the NASDAQ 100 index

Is Waters in the Dow Jones?

No, Waters is not included in the Dow Jones index

When was Waters the previous earnings report?

No data

When does Waters earnings report?

The next expected earnings date for Waters is 07 November 2024